We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

330 hedge funds and large institutions have $3.55B invested in Sabra Healthcare REIT in 2018 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 108 increasing their positions, 118 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more call options, than puts

Call options by funds: $6.65M | Put options by funds: $4.41M

27% more capital invested

Capital invested by funds: $2.8B → $3.55B (+$746M)

15% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 34

2.56% more ownership

Funds ownership: 88.95%91.51% (+2.6%)

1% more funds holding

Funds holding: 327330 (+3)

8% less repeat investments, than reductions

Existing positions increased: 108 | Existing positions reduced: 118

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
330
Holders Change
+3
Holders Change %
+0.92%
% of All Funds
7.55%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
39
Increased
108
Reduced
118
Closed
34
Calls
$6.65M
Puts
$4.41M
Net Calls
+$2.25M
Net Calls Change
+$4.67M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$26.4M +$1.26M +64,647 +6%
Wells Fargo
27
Wells Fargo
California
$25.4M -$534K -27,349 -2%
Russell Investments Group
28
Russell Investments Group
United Kingdom
$25.3M +$20.3M +1,036,891 +850%
FM
29
Forward Management
California
$23.1M -$1.98M -101,175 -9%
Invesco
30
Invesco
Georgia
$20.9M -$3.07M -157,401 -14%
TA
31
Teachers Advisors
New York
$20M +$7.22M +369,544 +67%
N
32
Nuveen
North Carolina
$19.8M -$20.4M -1,046,120 -53%
B
33
Barings
North Carolina
$19.8M +$17.8M +909,479 New
Deutsche Bank
34
Deutsche Bank
Germany
$18.4M -$30.8K -1,577 -0.2%
Principal Financial Group
35
Principal Financial Group
Iowa
$17.1M +$20.2K +1,034 +0.1%
SFM
36
Systematic Financial Management
New Jersey
$16.8M +$1.55M +79,128 +11%
Morgan Stanley
37
Morgan Stanley
New York
$16.5M -$1.91M -97,902 -11%
Ameriprise
38
Ameriprise
Minnesota
$16.1M -$275K -14,068 -2%
TCM
39
Tekla Capital Management
Massachusetts
$15.7M
Legal & General Group
40
Legal & General Group
United Kingdom
$14.9M -$181K -9,282 -1%
Janus Henderson Group
41
Janus Henderson Group
United Kingdom
$13.7M -$3.1M -158,481 -20%
VRS
42
Virginia Retirement Systems
Virginia
$12.9M +$355K +18,200 +3%
GXMC
43
Global X Management Company
New York
$12.5M -$37K -1,893 -0.3%
JP Morgan Chase
44
JP Morgan Chase
New York
$12M +$4.54M +232,420 +72%
SEI Investments
45
SEI Investments
Pennsylvania
$11.7M +$6.23M +319,169 +147%
UBS AM
46
UBS AM
Illinois
$11.1M -$24.4K -1,250 -0.2%
AIG
47
American International Group
New York
$10.2M +$101K +5,152 +1%
UBS Group
48
UBS Group
Switzerland
$10M +$2.15M +109,864 +31%
WA
49
Wasatch Advisors
Utah
$9.65M -$1.35M -69,334 -14%
CS
50
Credit Suisse
Switzerland
$9.59M -$489K -25,037 -5%

SBRA Hedge Fund Activity: Q2 2018 in Review

330 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q2 2018, worth a combined $3.55B — up 27% from $2.8B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new SBRA positions and 34 closed out — a net gain of 5 holders — while 108 added to existing stakes and 118 trimmed.

The largest buyer was Cohen & Steers, adding an estimated $190M. The largest seller was Balyasny Asset Management, cutting an estimated $33.5M.

  • 330 institutional investors held Sabra Healthcare REIT (SBRA) as of Q2 2018, up from 327 in Q1 2018.
  • Funds reported $3.55B of Sabra Healthcare REIT stock for Q2 2018, up 27% quarter-over-quarter.
  • 39 funds opened new Sabra Healthcare REIT positions in Q2 2018 and 34 closed out, a net change of +5 holders.
  • The largest Sabra Healthcare REIT buyer in Q2 2018 was Cohen & Steers, an estimated $190M added.
  • The largest Sabra Healthcare REIT seller in Q2 2018 was Balyasny Asset Management, an estimated $33.5M sold.

Based on aggregated 13F filings for Q2 2018.